When will it be ready for diagnostic use in India?

Mr Lucier: Already a couple of diagnostic labs are working on Ion Torrent technology. What needs to be done in diagnostics is validation by the regulatory authority that may take six-to-nine months. The labs have already started looking at what could be the possible applications of this product, which is needed to get a final approval from regulatory authorities. By the next year, DCGI and other regulatory agencies will have robust data on Ion Torrent, which will help us take the product to the market after the approval.

The industry is of the opinion that affordability is key to enter emerging markets like India. What are your thoughts on affordability of the product?

Mr Lucier: We need to look at the functionality of the product. Last year, the same kind of product cost over $500,000. We see a massive economic shift happening in research and development. This proton device will run on two chips so far. In future, chips will be able to add more value to genetic sequencing. We are already working closely with regulatory agencies for commercializing the product.

Are you planning to invest in a manufacturing facility and increase resources in the country?